You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Comparison between survivors and non-survivors

From: Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases

  Non-survivors Survivors
n = 5 (%) n = 11 (%)
Male 1 (20) 6 (55)
Agea 66.8 (46–81) 79.8 (51–96)
Underlying conditions
 Serum albumin (g/dL)ab 2.0 (1.5–2.6) 2.4 (1.1–4.2)
 HTLV-1c 3 (75) 8 (80)
 Steroid user 2 (40) 3 (27)
 Anti-cancer drug 0   1  
Underlying disease
 Adult T-cell lymphoma/leukemia 1 (20) 4 (27)
 Type 2 diabetes mellitus 2 (40) 1 (9)
Cases with pulmonary complication 5 (100) 10 (91)
 Acute respiratory distress syndrome 4   4  
 Pulmonary alveolar hemorrhage 1   2  
Other complication
 Systemic infection 5 (100) 5 (45)
  Sepsis 4   4  
Meningitis 3   2  
 Ileus 1 (20) 3 (27)
  1. Abbreviations: HTLV-1 = human T-cell leukemia virus type 1, amean (range) was used for these values, btotal 13 cases (3 non-survivors and 10 survivors) were tested serum albumin, ctotal 14 cases (4 non-survivors and 10 survivors) were tested HTLV-1